Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 020381 Product 002 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N020381 002 6080428 May 27, 2017 U - 331
N020381 002 6080428 May 27, 2017 U - 1138
N020381 002 6080428 May 27, 2017 U - 1139
N020381 002 6080428 May 27, 2017 U - 1140
N020381 002 6080428 May 27, 2017 U - 1141
N020381 002 6129930 Sep 20, 2013 Y U - 354
N020381 002 6129930 Sep 20, 2013 Y U - 1138
N020381 002 6129930 Sep 20, 2013 Y U - 1139
N020381 002 6129930 Sep 20, 2013 Y U - 1140
N020381 002 6129930 Sep 20, 2013 Y U - 1141
N020381 002 6406715 Sep 20, 2013 Y U - 450
N020381 002 6469035 Mar 15, 2018 U - 768
N020381 002 6469035 Mar 15, 2018 U - 1142
N020381 002 6469035 Mar 15, 2018 U - 1143
N020381 002 6469035 Mar 15, 2018 U - 1144
N020381 002 6469035 Mar 15, 2018 U - 1145
N020381 002 6676967 Sep 20, 2013 U - 548
N020381 002 6676967 Sep 20, 2013 U - 1138
N020381 002 6676967 Sep 20, 2013 U - 1139
N020381 002 6676967 Sep 20, 2013 U - 1140
N020381 002 6676967 Sep 20, 2013 U - 1146
N020381 002 6746691 Sep 20, 2013 Y U - 586
N020381 002 6818229 Sep 20, 2013 Y
N020381 002 7011848 Sep 20, 2013 U - 712
N020381 002 7011848 Sep 20, 2013 U - 1140
N020381 002 7011848 Sep 20, 2013 U - 1141
N020381 002 7011848 Sep 20, 2013 U - 1147
N020381 002 7011848 Sep 20, 2013 U - 1148
N020381 002 7998506 Sep 20, 2013 U - 1138
N020381 002 7998506 Sep 20, 2013 U - 1139
N020381 002 7998506 Sep 20, 2013 U - 1140
N020381 002 7998506 Sep 20, 2013 U - 1141

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through March 01, 2014
Patent and Generic Drug Product Data Last Updated April 18, 2014

-
-